Fetal hemolytic anemia associated with maternal sulfasalazine therapy during pregnancy.
Bokström
Hans
H
Institute for the Health of Women and Children, Sahlgrenska University Hospital/East, Goteborg, Sweden. hans.i.bokstrom@vgregion.se
Holst
Rose-Marie
RM
Hafström
Ola
O
Swolin
Birgitta
B
Johansson
Mari Louise
ML
Brunlöf
Gertrud
G
Hedner
Thomas
T
D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000628:therapy; D001805:Blood Transfusion, Intrauterine; D003093:Colitis, Ulcerative / Q000188:drug therapy; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced* / Q000628:therapy; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects*
D005765:Gastrointestinal Agents; D006454:Hemoglobins; D012460:Sulfasalazine